Skip to main content
Caplight Logo









Obat

Obat

Private
NantesEnterprise Softwarehttps://www.obat.fr/

Last Round

Series A

Nov 23, 2023

Total Funding Raised

$19.06M

Company Overview

Obat is a SaaS company that develops invoicing and payment software intended to serve small and medium enterprises in the construction industry.

Sector

Enterprise Software

Verticals

Construction Tech, Vertical SaaS, Project Management, Accounting & Expense, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

construction softwarevertical SaaSconstruction managementinvoicing softwarequote generationBTP softwaresite managementproject trackingartisans softwarefield service managementworkflow automationproptechcontechbilling softwaremobile construction app

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Obat Comparables

Compare Obat with similar companies based on industry and business-model similarity.

Obat comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Graneet
89%
Costructor
88%
Vertuoza
87%

Obat Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 23, 2023
SeedSep 15, 2022

Key People

Founding team and executive leadership

Antony Girault

CIO - Co-Founder

Founding Team

Florent Liagre

Co-founder CEO

Founding Team

Rachid Ouaddour

Chief Financial Officer

Executive Team

Obat Investors

Notable investors and investment history

Obat investors
InvestorRounds
Kima VenturesSeries A
New Alpha Asset ManagementSeries A
HolnestSeed, Series A
NCISeries A
Crédit Mutuel InnovationSeries A
EvolemSeed, Series A
BpifranceSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 23, 2023

    $13M round led by Crédit Mutuel Innovation, NCI, New Alpha Asset Management, and Kima Ventures.

  • Sep 15, 2022

    $6M round led by Truffle Capital.

Obat Filings

Explore SEC and related filing metadata, where available.

Obat filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Obat's valuation, stock price, and market status.

Is Obat a public or private company?

Obat is a private company.

What is the current stock price of Obat?

Obat is a private company with no public stock price. No recent secondary market data is available.

How much is Obat worth (valuation)?

Valuation information for Obat is not publicly available.

Can I buy Obat stock?

Obat shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Obat's last funding round?

Obat's most recent funding round was Series A on November 23, 2023.

Who are the main investors in Obat?

Key investors in Obat include Kima Ventures, New Alpha Asset Management, NCI, Crédit Mutuel Innovation, Truffle Capital.

Will Obat IPO soon?

No public IPO plans have been announced for Obat.

How can I track Obat secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Obat's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNantes
Employee Range103
Year Founded2019
Last FundingNov 23, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?